Identifying Age Based Maturation in the ERP Response to Faces in Children With Autism: Implications for Developing Biomarkers for Use in Clinical Trials.
Saved in:
| Title: | Identifying Age Based Maturation in the ERP Response to Faces in Children With Autism: Implications for Developing Biomarkers for Use in Clinical Trials. |
|---|---|
| Authors: | Webb SJ; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States.; Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States., Emerman I; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States., Sugar C; Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Statistics, University of California, Los Angeles, Los Angeles, CA, United States., Senturk D; Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Statistics, University of California, Los Angeles, Los Angeles, CA, United States., Naples AJ; Yale Child Study Center, Yale University, New Haven, CT, United States., Faja S; Harvard Medical School, Harvard University, Boston, MA, United States.; Department of Neurology, Boston Children's Hospital, Boston, MA, United States., Benton J; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States., Borland H; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States., Carlos C; Yale Child Study Center, Yale University, New Haven, CT, United States., Levin AR; Harvard Medical School, Harvard University, Boston, MA, United States.; Department of Neurology, Boston Children's Hospital, Boston, MA, United States., McAllister T; Yale Child Study Center, Yale University, New Haven, CT, United States., Santhosh M; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States., Bernier RA; Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States., Chawarska K; Yale Child Study Center, Yale University, New Haven, CT, United States., Dawson G; Duke Center for Autism and Brain Development, Duke University, Durham, NC, United States.; Department of Psychiatry & Behavioral Sciences, Duke University, Durham, NC, United States., Dziura J; Yale Center for Clinical Investigation, Yale University, New Haven, CT, United States., Jeste S; Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Neurology, Children's Hospital of Los Angeles, Los Angeles, CA, United States., Kleinhans N; Center on Human Development and Disabilities, University of Washington, Seattle, WA, United States.; Department of Radiology, University of Washington School of Medicine, Seattle, WA, United States., Murias M; Duke Center for Autism and Brain Development, Duke University, Durham, NC, United States.; Medical Social Sciences, Northwestern University, Chicago, IL, United States., Sabatos-DeVito M; Department of Psychiatry & Behavioral Sciences, Duke University, Durham, NC, United States., Shic F; Center on Child Health, Behavior, & Development, Seattle Children's Research Institute, Seattle, WA, United States.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States., McPartland JC; Yale Child Study Center, Yale University, New Haven, CT, United States. |
| Corporate Authors: | Autism Biomarkers Consortium for Clinical Trials |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2022 May 09; Vol. 13, pp. 841236. Date of Electronic Publication: 2022 May 09 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-0640 |
|---|---|
| DOI: | 10.3389/fpsyt.2022.841236 |
